The selective m1 muscarinic antagonist MT-7 blocks pilocarpine-induced striatal Fos expression

Brain Research

Volumn 1085, Issue 1, 2006, Pages 127-131

  Wirtshafter, David ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Acetylcholine; c fos; Caudate; Cholinergic; Immediate early gene; m1 toxin1; MT 7

Indexed keywords

AMPHETAMINE; MT 7; MUSCARINIC AGENT; MUSCARINIC M1 RECEPTOR; MUSCARINIC M1 RECEPTOR ANTAGONIST; PILOCARPINE; PROTEIN FOS; SNAKE VENOM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BRAIN FUNCTION; CHOLINERGIC ACTIVITY; CONTROLLED STUDY; DRUG EFFECT; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STRIATE CORTEX;

ANIMALS; CELL COUNT; CORPUS STRIATUM; ELAPID VENOMS; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MALE; MUSCARINIC AGONISTS; MUSCARINIC ANTAGONISTS; PILOCARPINE; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY;

CROCODYLUS NILOTICUS;

EID: 33646541379     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.02.022     Document Type: Article

References (27)

1. Adem A., Jolkkonen M., Bogdanovic N., Islam A., and Karlsson E. Localization of m1 muscarinic receptors in rat brain using selective muscarinic toxin-1. Brain Res. Bull. 44 (1997) 597-601
2. Ashkenazi A., Peralta E.G., Winslow J.W., Ramachandran J., and Capon D.J. Functional diversity of muscarinic receptor subtypes in cellular signal transduction and growth. TIPS (1989) 16-22 (Suppl.)
3. Bernard V., Normand E., and Bloch B. Phenotypical characterization of the rat striatal neurons expressing muscarinic receptor genes. J. Neurosci. 12 (1992) 3591-3601
4. Bernard V., Dumartin B., Lamy E., and Bloch B. Fos immunoreactivity after stimulation or inhibition of muscarinic receptors indicates anatomical specificity for cholinergic control of striatal efferent neurons and cortical neurons in the rat. Eur. J. Neurosci. 5 (1993) 1218-1225
5. Bontempi B., and Sharp F.R. Systemic morphine-induced Fos protein in the rat striatum and nucleus accumbens is regulated by μ opioid receptors in the substantia nigra and ventral tegmental area. J. Neurosci. 17 (1997) 8596-8612
6. Bradley K.N., Rowan E.G., and Harvey A.L. Effects of muscarinic toxins MT2 and MT7, from green mamba venom, on m1, m3 and m5r muscarinic receptors expressed in Chinese hamster ovary cells. Toxicon 41 (2003) 207-215
7. Cook D.F., and Wirtshafter D. Quinpirole attenuates striatal c-fos induction by serotonin, opioid and muscarinic receptor agonists. Eur. J. Pharmacol. 349 (1998) 41-47
8. Hughes P., and Dragunow M. Muscarinic receptor-mediated induction of Fos protein in rat brain. Neurosci. Lett. 150 (1993) 122-126
9. Hughes P., and Dragunow M. Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system. Pharmacol. Rev. 47 (1995) 133-178
10. Hulme E.C., Birdsall N.J.M., and Buckley N.J. Muscarinic receptor subtypes. Annu. Rev. Pharmacol. Toxicol. 30 (1990) 63-673
11. Jolkkonen M. Muscarinic toxins from Dendroaspis (Mamba) venom. Acta Univ. Ups. 183 (1996) 2-52
12. Kukkonen A., Perakyla M., Akerman K.E.O., and Nasman J. Muscarinic toxin 7 selectivity is dictated by extracellular receptor loops. J. Biol. Chem. 49 (2004) 50923-50929
13. Levey A.I., Kitt C.A., Simonds W.F., Price D.L., and Brann M.R. Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies. J. Neurosci. 11 (1991) 3218-3226
14. Liang J., Gutierrez-Ford C., and Potter L.T. Sustained unilateral blockade of rat striatal M1 muscarinic receptors with m1-toxin1 in vivo. Brain Res. 921 (2001) 211-218
15. Marchi M., Volpe G., Augliera A., Codignola A., Lunardi G., and Raiteri M. Cholinergic modulation of dopamine release in corpus striatum and substantia nigra of the rat. Neurochem. Int. 20 (1992) 271S-274S (Suppl.)
16. Nasman J., Jolkkonen M., Ammoun S., Karlsson E., and Akerman K.E.O. Recombinant expression of a selective blocker of M1 muscarinic receptors. Biochem. Biophys. Res. Commun. 271 (2000) 435-439
17. Onali P., Adem A., Karlsson E., and Olianas M.C. The pharmacological action of MT-7. Life Sci. 76 (2005) 1547-1552
18. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1997), Academic Press, New York
19. Potter L.T., Flynn D.D., Liang J.S., and McCollum M.H. Studies of muscarinic neurotransmission with antimuscarinic toxins. Prog. Brain Res. 145 (2004) 121-128
20. Purkerson S.L., and Potter L.T. Use of antimuscarinic toxins to facilitate studies of striatal m4 muscarinic receptors. J. Pharmacol. Exp. Ther. 284 (1998) 707-713
21. Raiteri M., Leardi R., and Marchi M. Heterogeneity of presynaptic muscarinic receptors regulating neurotransmitter release in the rat brain. J. Pharmacol. Exp. Ther. 228 (1984) 209-214
22. Robertson G.S., Vincent S.R., and Fibiger H.C. D1 and D2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons. Neuroscience 49 (1992) 285-296
23. Smolders I., Bogaert L., Ebinger G., and Michotte Y. Muscarinic modulation of striatal dopamine, glutamate, and GABA release, as measured with in vivo microdialysis. J. Neurochem. 68 (1997) 1942-1948
24. Wirtshafter D. Role of dopamine D1 receptors in the striatal and cortical fos expression induced by the muscarinic agonist pilocarpine. Eur. J. Pharmacol. 488 (2004) 85-90
25. Wirtshafter D., and Osborn C.V. The distribution of m4 muscarinic acetylcholine receptors in the islands of Calleja and striatum of rats and cynomolgus monkeys. J. Chem. Neuroanat. 28 (2004) 107-116
26. Yan Z., Flores-Hernandez J., and Surmeier D.J. Coordinated expression of muscarinic receptor messenger RNAs in striatal medium spiny cells. Neuroscience 103 (2001) 1017-1024
27. Zhang W., Yamada M., Gomeza J., Basile S., and Weiss J. Multiple muscarinic acetylcholine receptor subtypes modulate striatal dopamine release, as studied with M1-M5 muscarinic receptor knockout mice. J. Neurosci. 22 (2002) 6347-6352